BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1610705)

  • 21. Lupus erythematosus.
    Hymes SR; Jordon RE; Arnett FC
    Dermatol Clin; 1986 Apr; 4(2):267-76. PubMed ID: 3955897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review.
    Sontheimer RD
    Photochem Photobiol; 1996 May; 63(5):583-94. PubMed ID: 8628749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I.
    Gerl V; Hostmann B; Johnen C; Waka A; Gerl M; Schumann F; Klein R; Radbruch A; Hiepe F
    Arthritis Rheum; 2005 Feb; 52(2):531-8. PubMed ID: 15692985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Ro/SSA antigen-antibody system. Studies of the effect of UVA-/PUVA irradiation and fibroblast activity on immune reaction with autoantibodies].
    Wollina U; Beensen V; Knopf B
    Z Hautkr; 1989 Dec; 64(12):1130-4. PubMed ID: 2699134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution.
    Caricchio R; McPhie L; Cohen PL
    J Immunol; 2003 Dec; 171(11):5778-86. PubMed ID: 14634086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Valsecchi L; Quinzanini M; Zane C; Facchetti F; Airò P; Cattaneo R
    Adv Exp Med Biol; 1999; 455():167-71. PubMed ID: 10599339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ro/SSA antigen in human epidermis.
    Jones SK; Coulter S; Harmon C; Norris DA; Rosandich M; Lee LA
    Br J Dermatol; 1988 Mar; 118(3):363-7. PubMed ID: 3258526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSA/Ro antigen expression in simian virus 40-transformed human keratinocytes.
    Miyagawa S; Okada N; Inagaki Y; Kitano Y; Ueki H; Sakamoto K; Steinberg ML
    J Invest Dermatol; 1988 Mar; 90(3):342-5. PubMed ID: 2450143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytotoxic effect of neonatal lupus erythematosus and maternal sera on keratinocyte cultures is complement-dependent and can be augmented by ultraviolet irradiation.
    Yu HS; Chiang LC; Chang CH; Kang JW; Yu CL
    Br J Dermatol; 1996 Aug; 135(2):297-301. PubMed ID: 8881678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.
    Casciola-Rosen LA; Anhalt G; Rosen A
    J Exp Med; 1994 Apr; 179(4):1317-30. PubMed ID: 7511686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitive forms of lupus erythematosus.
    Ioannides D; Golden BD; Buyon JP; Bystryn JC
    Arch Dermatol; 2000 Mar; 136(3):340-6. PubMed ID: 10724195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin.
    Lee LA; Harmon CE; Huff JC; Norris DA; Weston WL
    J Invest Dermatol; 1985 Aug; 85(2):143-6. PubMed ID: 3926904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-dependent cellular cytotoxicity and skin disease.
    Norris DA; Lee LA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):165s-175s. PubMed ID: 3874244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients.
    Davis TL; Lyde CB; Davis BM; Sontheimer RD
    J Invest Dermatol; 1989 Apr; 92(4):573-7. PubMed ID: 2703725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparate locations of the 52- and 60-kDa Ro/SS-A antigens in cultured human keratinocytes.
    Yell JA; Wang L; Yin H; McCauliffe DP
    J Invest Dermatol; 1996 Oct; 107(4):622-6. PubMed ID: 8823371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytotoxic effect on human keratinocytes caused by anti-Ro-(SS-A) antibodies and UVA in vitro].
    Brink I; Böhm F; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1990; 176(11):701-6. PubMed ID: 2083611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune response to the Ro/SSA particle is directed to the human antigen.
    Reichlin M; Rader M; Harley JB
    Clin Exp Immunol; 1989 Jun; 76(3):373-7. PubMed ID: 2473859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice.
    Lee LA; Gaither KK; Coulter SN; Norris DA; Harley JB
    J Clin Invest; 1989 May; 83(5):1556-62. PubMed ID: 2651477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.